SynthesisFrontiers in oncology2025
Systematic review of artificial intelligence and radiomics for preoperative prediction of extranodal extension and lymph node metastasis in oropharyngeal cancer.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review.Frontiers in oncology · 2026Pooled it
- Artificial Intelligence-Based 18F-FDG PET/CT Radiomics for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer: A Systematic Review.Diagnostics (Basel, Switzerland) · 2026Review
- Risk factors and development of a prediction model for hematoma expansion in elderly patients with spontaneous intracerebral hemorrhage.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative identification of extranodal extension (ENE) and cervical lymph node metastasis (LNM) in oropharyngeal cancer guides treatment escalation and de-escalation. Artificial intelligence (AI) and radiomics offer promise for nodal assessment, but clinical utility and reporting quality remain variable. Methods: This systematic review followed PRISMA guidelines. We systematically searched PubMed, Scopus, and Web of Science for studies published between 2020-2025. Eleven eligible studies (4 core, 7 supportive) addressed ENE (n=2) or LNM prediction (n=2), with additional supportive studies on segmentation, lymphatic spread modeling, MRI radiomics, and outcomes modeling. Extracted variables included study characteristics, performance metrics, validation, calibration, and unit of analysis. Risk of bias was assessed using PROBAST; reporting quality was evaluated with TRIPOD. Due to heterogeneity and limited study numbers, no meta-analysis was performed; results were narratively synthesized. For ENE, we report study-level accuracy, decision-curve analysis (DCA), and per-1,000 management impact. Results: All core studies were CT-based. The task-specific deep-learning ENE model achieved AUC 0.86 with balanced operating points, while the generalist LVLM (Large Vision-Language Model) reached sensitivity 1.00 with specificity 0.34. DCA favored the DL model across thresholds 0.10-0.40, showing fewer unnecessary dissections per 1,000 patients than Treat-all or L(V)LM. For LNM, discrimination was high (AUC 0.865-0.919), calibration was reported, and one study included external validation, though threshold-level sensitivity/specificity were missing. External validation was reported in 25% of core studies, calibration in 50%; TRIPOD adherence was 74.5% overall, with frequent under-reporting of blinding and missing-data handling. Conclusions: AI and radiomics show promising potential for preoperative prediction of ENE and LNM in oropharyngeal cancer. Task-specific deep-learning models achieve balanced discrimination, while generalist LVLMs provide high recall at lower specificity. For LNM, encouraging performance is reported, but limited external validation and absent standardized thresholds still preclude clinical use. Broader validation and harmonized reporting are essential before translation into practice. Registration/Protocol: Not registered; methods followed PRISMA/TRIPOD/PROBAST guidance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.